About
Abilita Therapeutics develops novel therapeutics targeting membrane proteins previously considered undruggable, using its proprietary EMP™ technology based on directed evolution to enable drug discovery and optimization.
Explore Abilita Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.